Bliss GVS Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma Limited has submitted its financial results to the NSE for the half-year period ended September 30, 2025. This is a routine regulatory filing covering the company's performance for H2 of calendar year 2025. The actual financial figures, including revenue, profit, and margins, are not provided in the filing notice itself. Investors will need to refer to the detailed results document for the full numbers and management commentary.
This is a mandatory disclosure with no direct price action expected from the submission alone. Shareholders should review the detailed results to assess the company's revenue trends, profitability, and segment performance for the period.